JPRN-UMIN000040157尚未招募未知
Prospective clinical study aiming at the improvement of hepatic encephalopathy and hepatic functional reserve of patients with liver cirrhosis by the secretory laxative agate lubiprostone - Improvement of hepatic encephalopathy and hepatic functional reserve by lubiprostone
ara Medical University Gastroenterology0 个研究点目标入组 60 人开始时间: 2020年4月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. <=19 y.o. or 81 y.o.<= 2. pregnancy or breast-feeding 3. have ever taken lubiprostone 4. heart failure (admission by 6 months) 5. renal severe failure(eGFR<30 ml/min/1.73m2) 6. serum sodium <125mEq/L or >150mEq/L 7. Cerebral infarction without paralysis and lacunar infarction 8. Dementia more than Performance Status 2 9. abdominal surgery career (stomach segmental resection or intestinal tract excision) 10. with taking opioid agents 11. change or increase diuretic agents for obserbation period 12. with infectious disease or gastrointestinal breeding 13. with malignant tumor 14. patients of refusal this trial 15. The patient who judged that this study responsibility doctor and allotment doctor were inadequate
研究者
相似试验
招募中
Unknown
Prospective interventional clinical study to evaluate the efficacy and safety of atezolizumab plus bevacizumab in combination with carbon ion radiotherapy for unresectable hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000051549Yamagata University20
招募中
不适用
Prospective study for clinical effectiveness and safety of TAZ/PIPC for the prevention of infectious complication of high risk lung cancer surgeryMalignant lung tumorJPRN-UMIN000003532Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University50
招募中
不适用
Clinical prospective study to investigate efficacy and safety of immune-cell therapy for malignant tumorsMalignant tumorJPRN-UMIN000004610Kanazawa university600
已完成
不适用
Clinical prospective study to investigate efficacy of NK cell therapy for malignant tumors.JPRN-UMIN000008046Seta Clinic Group20
已完成
不适用
Clinical prospective study to investigate efficacy of WT1 peptide (PepTivator(R))-pulsed dendritic cell vaccination therapyMalignant tumor (all HLA types)JPRN-UMIN000009447Seta Clinic Group5